1990
DOI: 10.1016/0014-2999(90)90327-3
|View full text |Cite
|
Sign up to set email alerts
|

The role of α1-adrenoceptor subtypes in the regulation of arterial blood pressure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

1991
1991
1998
1998

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(3 citation statements)
references
References 3 publications
0
3
0
Order By: Relevance
“…Several pharmacological and molecular studies (Hanft and Gross, 1989;Minneman et al, 1988;Morrow and Creese, 1986;Piascik et al, 1990;Terman et al, 1990;Wilson and Minneman, 1989) have shown that al-adrenoceptors could be subdivided into three different subtypes, a1 A, a1 B, and a1 C, which could possibly use different biochemical mechanisms for signal transduction (Han et al, 1987a,b;Johnson and Minneman, 1987;Morrow and Creese, 1986). Moreover, it has been proposed recently that Prazosin could be considered at high concentration as a selective antagonist for a2adrenoceptors and particularly for a 2 B and a 2 C subtypes which have very similar but distinct pharmacological profiles (Harrison et al, 1991;Akers et al, 1991).…”
Section: Discussionmentioning
confidence: 99%
“…Several pharmacological and molecular studies (Hanft and Gross, 1989;Minneman et al, 1988;Morrow and Creese, 1986;Piascik et al, 1990;Terman et al, 1990;Wilson and Minneman, 1989) have shown that al-adrenoceptors could be subdivided into three different subtypes, a1 A, a1 B, and a1 C, which could possibly use different biochemical mechanisms for signal transduction (Han et al, 1987a,b;Johnson and Minneman, 1987;Morrow and Creese, 1986). Moreover, it has been proposed recently that Prazosin could be considered at high concentration as a selective antagonist for a2adrenoceptors and particularly for a 2 B and a 2 C subtypes which have very similar but distinct pharmacological profiles (Harrison et al, 1991;Akers et al, 1991).…”
Section: Discussionmentioning
confidence: 99%
“…This effects of the Pz-agonists terbutaline and fenoterol could be connected with their intracellular CAMP-increasing effects (11) The relaxant effect of the selective a,-antagonist yohimbine could play a role in the blockade of the a,-receptor-linked Ca*'-channels (12), besides the increase in the CAMP level (13). It is very probable that the inhibitory effect of the selective al-antagonist urapidil can be explained by inhibition of those Ca**-channels functionally coupled to the al-receptor subtypes (14). A further explanation may be given the inhibition of endogenous ATP-release by the al-receptor blockers (15).…”
Section: Discussionmentioning
confidence: 99%
“…1993). Interestingly, pharmacological studies have shown a predominant role for ala-adrenoceptors in the maintenance of vascular tone and systemic arterial pressure in rats (Piascik et al 1990; Vargas et al 1993). Thus, it could be speculated that a possible selectivity of YM617 for al-adrenoceptor subtype accounts for the observed difference in al-adrenoceptor binding affinity between the prostate and the aorta of human.…”
Section: Discussionmentioning
confidence: 99%